What is Utah Medical Products's D&A?

Utah Medical Products (UTMD) reported D&A of $462K in Q1 2026.

How has Utah Medical Products's D&A changed year-over-year?

Utah Medical Products's D&A decreased by 9.2% year-over-year, from $509K to $462K.

What is the long-term trend for Utah Medical Products's D&A?

Over 4 years (2021 to 2025), Utah Medical Products's D&A has grown at a -24.8% compound annual growth rate (CAGR), from $6.65M to $2.13M.

Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.

Utah Medical Products UTMD D&A

D&A at other companies

TFX

TeleflexTFX

$53.74M+39.2%

The Cooper Companies, Inc.COO

$47.7M-4.2%

Merit Medical SystemsMMSI

$30.5M+4.1%

PDE

Pro-Dex, Inc.PDEX

$363K+17.2%

Pediatrix Medical GroupMD

$6.12M+14.8%

InfuSystem HoldingsINFU

$209K-15.7%

Other financials

Income statement

See full

Revenue$8.7M-10.2%

Gross profit$5.3M-4.6%

Operating income$2.6M-18.6%

Net income$2.6M-14.4%

EPS (diluted)$0.82-10.9%

Balance sheet

See full

Cash & equivalents$87.4M+4.9%

Total debt$210.0K—

Total equity$120.4M+2.8%

Total assets$124.4M+1.5%

Cash flow

See full

Operating cash flow$3.1M-30.4%

CapEx$130.0K-29.3%

Free cash flow$3.0M-30.4%

Valuation

See full

Market cap$219.63M+26.4%

Enterprise value$132.44M+42.5%

P/E20.3×+6.4×

P/S5.9×+1.4×

Profitability

See full

Gross margin57.9%-0.4pp

Operating margin28.8%-3.9pp

Net margin28.9%-4.1pp

FCF margin34.7%0.0pp

Returns & leverage

See full

Return on equity9.1%-1.4pp

Debt / equity0×—

Current ratio28.6×+6.3×

Where this comes from

Reported directly by Utah Medical Products in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The official record: Utah Medical Products’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Utah Medical Products's D&A?: Utah Medical Products (UTMD) reported D&A of $462K in Q1 2026.
How has Utah Medical Products's D&A changed year-over-year?: Utah Medical Products's D&A decreased by 9.2% year-over-year, from $509K to $462K.
What is the long-term trend for Utah Medical Products's D&A?: Over 4 years (2021 to 2025), Utah Medical Products's D&A has grown at a -24.8% compound annual growth rate (CAGR), from $6.65M to $2.13M.
What does D&A mean?: Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.